Robert Allen Burger, M.D., FACOG, FACS

faculty photo
Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Department: Obstetrics and Gynecology

Contact information
University of Pennsylvania
3400 Civic Center Blvd.
South Tower 10-173
Philadelphia, PA 19104-5156
Office: 215-220-9513
Fax: 215-220-9515
A.B. (Biochemistry)
Harvard University, Cambridge, MA, 1984.
New York University, New York, NY, 1988.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Rose PG, Java JJ, Salani R, Geller MA, Secord AA, Tewari KS, Bender DP, Mutch DG, Friedlander ML, Van Le L, Method MW, Hamilton CA, Lee RB, Wenham RM, Guntupalli SR, Muggia FM, Armstrong DK, Bookman MA, Burger RA, Copeland LJ: Nomogram Predicting Individual Survival Following Recurrence in Advanced Stage High Grade Ovarian Cancer from NRG/GOG Randomized Trials of Platinum and Paclitaxel. Obstetrics & Gynecology 133(2): 245-54, Feb 2019.

Fuh K, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS : Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7,914 patients. Gynecol Oncol In Press, 2019.

Nasioudis D, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Ko EM, Latif NA.: Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma. Gynecol Oncol In Press, 2019.

Nasioudis D, Ko EM, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Latif NA: Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors. Gynecologic Oncology Reports In Press, 2019.

Tewari KT, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.: Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer. J Clin Oncol In Press, 2019.

Moore KN, Gunderson C, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger R, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE : A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Gynecol Oncol In Press, 2019.

Nasioudis D, Ko E, Haggerty AF, Giuntoli RL II, Burger RA, Morgan RA, Latif N : Isolated distant lymph node metastases in ovarian cancer. Should a new sub-stage be created? Gynecologic Oncology Reports In Press, 2019.

Fruehauf JP, Parmakhtiar B, Burger RA, Kim J-H: HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity. Molecular Cancer Research In Press, 2019.

Cori L, Cha B, Ellenberg S, Bogner HR, Hwang W-T, Smith J, Haggerty A, Morgan M, Burger RA, Chu C, Ko E: The Impact of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial Obstetrics and Gynecology In Press, 2019.

Arend RC, Toboni M, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog T.: Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm. The Oncologist 12: 1533-1545, Dec 2018.

back to top
Last updated: 05/17/2019
The Trustees of the University of Pennsylvania